Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Bellagena Med Spa Joins The Exclusive Haute Beauty Network


News Image

Prepare for absolute radiance when you place your skin in the hands of the experts at Bellagena Skin Care Studio & Day Spa.

You’ve heard of skin that shines, but when you want skin that sparkles, visit Bellagena Skin Care Studio & Med Spa. Founded by Julia Carr with the vision to provide clinical skin treatments in a day spa ambiance, Bellagena’s full-service menu includes the best facials, massages and hair removal. Above all, the spa continues to flaunt its design as a skin treatment clinic that affords everyone the opportunity to love her skin.

Masterfully Created Skin Treatments To Fit Every Lifestyle

As much as Bellegena is a place to relax, it’s also the place to go when your skin needs resuscitation. Many factors, such as diet and exercise, are responsible for your skin’s radiance. By emphasizing this important tenant, the experts at Bellagena have masterfully created skin treatments to fit every lifestyle. They have made it their mission to give skin a revitalizing lift after years of neglect. Sporting signature facials, microdermabrasion, chemical peels, and the very best expertise in dermaplaning, every client can expect to emerge anew.

Expert Massage Therapies

The spa’s holistic approach also greets clients with a treasure trove of the best massages delivered by their expert massage therapists. Furthering healing is the goal with any of their custom massages that boost the immune system, alleviate pain and increase circulation.

Beauty Treatments That Relax Your Mind

Like massage affords relaxation to the body, let their beauty treatments relax your mind. An array of their best skin care treatments, massage therapy, microdermabrasion and infrared sauna are at your disposal. Combine any of these with aromatic body wraps and scrubs and you will have put your mind at ease while putting your best foot forward.

Prepare for absolute radiance when you place your skin in the hands of the experts at Bellagena Skin Care Studio & Day Spa.

Learn more about Bellagena Med Spa by visiting: https://hauteliving.com/hautebeauty/member/bellagena-med-spa/

ABOUT HAUTE BEAUTY NETWORK:

Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.

For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Share article on social media or email:

Motiva® by Establishment Labs Pledges Gold Level Sponsorship for 2022 Breast Reconstruction Awareness Day


News Image

The American Society of Plastic Surgeons (ASPS), the world’s largest organization of board-certified plastic surgeons, today announced Motiva® by Establishment Labs will participate as a Gold Level sponsor for the 11th annual Breast Reconstruction Awareness (BRA) Day on Oct. 19, 2022.

Many women who undergo a mastectomy or lumpectomy are unaware of the breast reconstruction options available to them, and BRA Day is designed to educate, engage and empower patients. BRA Day events across the world bring much needed attention to these procedures and provide information to patients and their supporters.

“As a company dedicated to women’s health, Establishment Labs is honored to support the 2022 Breast Reconstruction Awareness Day Campaign,” said Heather Brennan, General Manager, Global Markets. “We support women in all aspects of their breast health journey and encourage all women to prioritize their breast health and to make free and informed decisions for themselves and their bodies. The democratization of breast reconstruction globally is a core focus of Establishment Labs, and we continue to draw inspiration from the millions of women who confront breast cancer every year with dignity and strength.”

BRA Day brings together ASPS, The Plastic Surgery Foundation (The PSF), plastic surgeons specializing in breast surgery, nurse navigators, corporate partners, breast cancer support groups and organizations to coordinate events on Oct. 19. These events take place across the globe and include media events, Q&A sessions, lectures, flash mobs, fundraising parties, advertising campaigns, community events and more.

About Breast Reconstruction

Studies show that women who undergo breast reconstruction experience significant improvements in psychological, social and sexual well-being. Every patient deserves to learn about breast reconstruction options at the time of diagnosis. In fact, the two main reasons women do not undergo breast reconstruction is that patients are not referred to breast reconstructive surgeons and are not informed of their reconstructive options. Breast reconstruction is part of a comprehensive approach and treatment for breast cancer patients.

A comprehensive team approach provides a cohesive breast cancer treatment plan. Integral to this cohesiveness are the frequent breast tumor board meetings that occur to discuss each individual patient and their individualized treatment. Members of this group of specialists are breast surgeons, plastic pathologists, reconstructive surgeons, oncologists, radiation oncologists, radiologists, geneticists, nurses, patient care coordinators and more. This team approach ensures that key decisions regarding each patient’s treatment are discussed and agreed upon by all team members. All aspects of care, from social to medical, are addressed at these meetings.

For more information on breast reconstruction, visit http://www.breastreconusa.org. Become educated and help educate others about the availability of breast reconstruction and why all women deserve a team approach to breast cancer treatment.

About ASPS

The American Society of Plastic Surgeons (ASPS) is the largest organization of board-certified plastic surgeons in the world. Representing nearly 8,000 physician members, the society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises more than 92 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada.

About Motiva® by Establishment Labs

Establishment Labs Holdings Inc. is a global medical technology company dedicated to improving women’s health and wellness. The company’s initial focus is breast health, principally breast aesthetics and reconstruction. Establishment Labs offers a portfolio of advanced silicone gel-filled breast implants, branded as Motiva Implants® that include a number of innovative and patented features designed to deliver improved aesthetic and clinical outcomes. Since commercial launch in 2010, over 2.0 million Motiva Implants® have been delivered to plastic surgeons in over 80 countries. The company also offers or has under development a number of related products and technologies, including the Motiva Flora® tissue expander and Mia Femtech®, the company’s minimally invasive breast enhancement procedure. In 2018, Establishment Labs received an investigational device exemption (IDE) from the FDA for the Motiva Implant® and began a clinical trial to support regulatory approval in the United States. Motiva Implants® are manufactured at the company’s two facilities in Costa Rica, which are compliant with all applicable regulatory standards under ISO13485:2016 and FDA 21 CFR 820 under the MDSAP program. Please visit our website for additional information at http://www.establishmentlabs.com.

###

Contact ASPS

Madison Freeman

Public Relations Coordinator

847.228.3333

media@plasticsurgery.org

Share article on social media or email:

HCAN and Zemplee Team Up to Tackle Professional Caregiver Shortage


Company Logo

“This dynamic partnership enables both organizations to further develop home care in the cloud. By combining technology and AI with a superior human touch and medical and clinical supervision through a remote patient monitoring solution, our combined efforts will better help seniors age in place.”

Former PayPal and eBay Executives Leverage Tech to Help Seniors Age in Place

The HomeCare Advocacy Network (HCAN) and Zemplee, a technology platform that utilizes attentive artificial intelligence (AI) and passive sensors to help seniors age safely in their homes, today announced they are joining forces to deliver a high-tech, hybrid mode of combined home care. Through this joint venture, the two companies will bundle their distinct services into an offering that will elevate the quality of care while addressing the pressing caregiver shortage.

Without cameras or microphones, Zemplee AI monitors a senior’s daily living activities, helping caregivers and family members remotely verify the senior’s health, wellbeing, and safety. The passive devices and attentive AI interprets dining habits, medication intake, activity level, sleep patterns, and other vital details. It then creates a behavioral determinant of health to ensure seniors can age safely in place.

“We are excited to now be able to deliver seniors and their families access to the real-time monitoring of vital statistics to, in turn, lower hospital readmission or trips to the emergency room,” said Mark Goetz, co-founder, and president of HCAN. “With a tight labor market and increased numbers of seniors aging in place, we need to become more tech-savvy to keep clients safe and healthy.”

Goetz, a PayPal alum, and Zemplee founder and CEO Aparna Pujar, a former eBay executive, have reimagined the symbiotic relationship that existed between their two previous companies to take on senior care, one of the fastest-growing industries in the country.

“This dynamic partnership enables both organizations to further develop home care in the cloud”, said Pujar. “By combining technology and AI with a superior human touch and medical and clinical supervision through a remote patient monitoring solution, our combined efforts will better help seniors age in place and have better life outcomes, while reducing care costs in the health system”.

Under the terms of the deal the two companies will cross promote their services and bundle their respective offerings. HCAN will also assist in the installation and activation of the Zemplee system in home, perform periodic checks of the system

For more information about the HomeCare Advocacy Network, visit hcanthrive.com.

To learn more about Zemplee, visit zemplee.com.

###

About HCAN

HCAN is a leading provider of meaningful and results-oriented home care connections for seniors and their loved ones. be the foremost provider of meaningful and results-oriented home care connections for seniors and their loved ones.

About Zemplee

Zemplee is a technology platform that utilizes Attentive AI and passive sensors to help the elderly age in place gracefully, with round-the-clock remote monitoring capabilities for caregivers that improves quality of life and reduces hospitalizations without comprising privacy. Co-founders Aparna Pujar and Gary Fowler combined decades of experience in Silicon Valley hi-tech companies and clinical care to develop artificial intelligence applications and unobtrusive sensors that power Zemplee’s innovative remote elderly care system.

Share article on social media or email:

capracare Founder and CEO, Jean Pierre-Louis Awarded a Proclamation at Queens Borough Caribbean Heritage Celebration


Founder and CEO, Jean Pierre-Louis of capracare was awarded a Proclamation from Queens Borough President Donovan Richards, Jr. at the Caribbean Heritage Celebration. The celebration took place on Tuesday, September 13, 2022, at Queens Museum.

Jean was recognized by the Queens Borough President for his work following the 2021 southern Haiti earthquake and for capracare’s ongoing efforts to improve the lives of those in Haiti.

“Queens is most grateful for the significant impact capracare has had in Haiti. I want to give hats off to you. Often these larger organizations…receive all this money, and we say, where does it go? Is it reaching the people? But this organization is on the ground ensuring the Haitian people have what they need and can continue to rebuild. Haitian resilience speaks for itself. Every time they are knocked down, they get back up, and that is partly because we have organizations like capracare which really cares for the people of Haiti.” said Queens Borough President Donovan Richards.

During his acceptance speech, Jean recounted being bullied in school. “I was only 9 years old, but those words served as my motivation. I committed to going back to Haiti to make it a better place to live. I not only wanted to ensure people had access to healthcare but also create jobs so it could be a more productive place. capracare has and will continue to play an integral role in the upward individual, social, and economic development of rural communities throughout the southern region of Haiti. ”

capracare, Inc. is a non-profit organization that provides medical care, preventative healthcare, mental health, education, and disaster relief to rural communities throughout the southern region of Haiti.

Share article on social media or email:

Kneevoice Selected by Pepperdine Graziadio Business School 2022 Most Fundable Companies


Take Control of Your Health

“We’re a 5 -year-old start-up with big ambitions, and recognition as a Most Fundable Company of 2022 positions us well for our next capital raise and brings us one step closer to achieving market leadership,” said Gustavo de Greiff CEO, Kneevoice

Kneevoice Inc. is delighted to announce that it achieved the GOLD recognition on the Pepperdine Graziadio Business School’s fifth annual Most Fundable Companies® List. Kneevoice Inc. competed against over 4,000 of early-stage US companies to be named one of 16 companies in total. The Most Fundable Companies initiative aims to educate founders on the investor diligence process and recognize exceptional entrepreneurs who are solving today’s problems with inventive solutions and are also seeking investment capital to fuel their company’s growth.

“We’re a 5 -year-old start-up with big ambitions, and recognition as a Most Fundable Company of 2022 positions us well for our next capital raise and brings us one step closer to achieving market leadership,” said Gustavo de Greiff CEO, Kneevoice “The Most Fundable Companies initiative was one of the most intensive diligence processes we’ve ever participated in, and we’re thrilled to have arrived on top through data-driven analysis. Entrepreneurial business ingenuity is the life blood of the US economy, and we’re excited that the Pepperdine Graziadio Business School is giving entrepreneurs a platform to showcase their business and set them up for success with investors.”

“I would like to thank Pepperdine Graziadio Business School for including Kneevoice in the Most Fundable Companies,” said Gustavo De Greiff, CEO, Kneevoice. “Early diagnosis is critical in preventing the onset and progression of patellofemoral cartilage damage. Kneevoice allows providers to assess the condition of the knee with the goal of preventing further damage. We are excited about finding the right partners to capture a share in the $15 billion US market, with an accurate, patient and physician-friendly solution that significantly prevents joint damage and reduces healthcare costs.”

As a winner on the Most Fundable Companies List, Kneevoice Inc. will be profiled on Entrepreneur.com and will be featured in the December print issue of Entrepreneur magazine. For a complete list of the winners, visit http://www.pepperdine.edu/mfc-list, where you can also vote for Kneevoice Inc. through October 24.

About Pepperdine Most Fundable Companies

The Most Fundable Companies List is an annual program hosted by the Pepperdine Graziadio Business School aimed to promote startup business development by providing pathways for startup funding and inspiring entrepreneurial spirit across the nation. More than 4,000 companies across all 50 states applied for the 2022 program. The Pepperdine Graziadio Business School’s Most Fundable Companies Showcase presented by the Singleton Foundation for Financial Literacy and Entrepreneurship took place on October 13, 2022 at Pepperdine University’s Villa Graziadio Executive Center.

The Most Fundable Companies program was launched by the Pepperdine Graziadio Business School in 2018 as a free resource to help entrepreneurs assess their readiness for private investment. The initiative involves a multi-phase assessment that evaluates several company variables, including financial projections, market opportunity, intellectual property, and the strength of the management team, all of which are used to generate objective and customized feedback and scoring to improve readiness for funding. Pepperdine Graziadio Business School’s Most Fundable Companies is powered by The Venture Alliance.

About Kneevoice

Designed to non-invasively capture the noises generated by the knee, Kneevoice evaluates cartilage damage while empowering people to take control of their health. Our easy-to-use, device will be used in the medical practitioner or physical therapist workplace. Kneevoice is developing a wearable device that will allow doctors and therapists the ability to monitor their patients from home. To learn more about Kneevoice visit http://www.kneevoice.com or follow us LinkedIn.

Contact:

Gustavo De Greiff,

gdegreiff@kneevoice.com

Disclaimers: The Pepperdine Most Fundable Companies list does not represent an offer to sell securities. It does not constitute investment advice, nor is it an endorsement of any particular product or service. Pepperdine University is not a broker-dealer and does not perform services provided by a broker-dealer, including but not limited to any financial or investment advising.

Share article on social media or email:

CornerLocTM Launches TransLoc 3D™ SI Joint Fusion System


TransLoc 3D™ by CornerLoc™

CornerLoc™ the trade name of Foundation Fusion Solutions, LLC, a medical device company, announces the much-anticipated launch of the TransLoc 3D™ SI Joint Fusion System. The TransLoc 3D™ SI Joint Fusion System is the next evolution in fixating the SI joint. The modular posterior implant and lateral oblique screw components of the TransLoc 3D™ System can be used together to create a truly 3-dimensional hybrid construct, or the screws can be used on their own as a transfixing compression construct.

“With our recent FDA 510(k) Clearance and launch of TransLoc 3D™, we are able to offer one of the most comprehensive SI joint fusion offerings available, giving the physician several implant options to match each patient’s needs. Incorporating CornerLoc’s patented and proven CornerLoc-ing technology*, together with state-of-the-art 3D printed titanium macro and micro porosity in the new ultra-porous posterior titanium implant and lateral oblique compression screw, this system offers a truly 3-dimensional approach to fusing the SI joint,” says Bob Compton, CEO and Co-founder of CornerLoc.

TransLoc 3D™ effectively fixates the SI Joint. TransLoc 3D™ Screws pass through the ilium, across the SI joint, and into the sacrum using a Lateral Oblique approach. This approach avoids sensitive anatomy, including the Gluteal artery, Gluteal nerves, and muscles that are potential obstacles of the straight Lateral approach. The TransLoc 3D™ System is intended to fixate the sacroiliac (SI) joint with the long-term goal of fusion. These titanium 3D-printed devices are available in a range of lengths and include a Posterior Implant version which can be used with the TransLoc 3D™ Screw. The TransLoc 3D™ Screws, using a Lateral Oblique approach, qualify for the CPT Panel’s new definition of transfixing**, which goes into effect January 1, 2023.

About CornerLoc™

CornerLoc™, headquartered in Tulsa, OK, was founded in 2017 on one idea: provide patients with an intelligent and lasting solution for SI joint fusion. The company has successfully been awarded a U.S. patent for the unique fixating features of theCornerLoc™ implant and has other U.S. patents pending. CornerLoc™ has offered the FDA registered CornerLoc™ graft since 2017, and has recently gained FDA 510(k) regulatory clearance for the TransLoc 3D™ system in the U.S. At CornerLoc™, we put the patient first in every decision we make and are driven by achieving positive outcomes and providing a life for our patients that is no longer dictated by chronic and debilitating pain. For more information, visit http://www.cornerloc.com.

References:

*Transfixation of the Sacroiliac Joint: Biomechanical Stability of a Dual-Implant Minimally Invasive Procedure; Antonio Valdevit, Ph.D., Steven Falowski, M.D., FAANS; SEA, Ltd., Columbus, OH, Argires-Marotti Neurosurgical Associates of Lancaster, Lancaster, PA

**New definition for transfixing to be used with Code 27279, which becomes effective January 1, 2023: placement of an internal fixation device(s) that passes through the ilium across the sacroiliac joint and into the sacrum. (CPT Category III codes long descriptors – updated July 1, 2022)

CPT © Copyright 2022 American Medical Association. All rights reserved. AMA and CPT are registered trademarks of the American Medical Association.

Share article on social media or email:

PDA Announces 2022 Drug Delivery Innovation Awards Winners


We are pleased to recognize the winners and all the companies considered at the first in-person Universe of Pre-Filled Syringes and Injection Devices Conference since 2019.

The Parenteral Drug Association (PDA) today announced the winners of the 2022 PDA Drug Delivery Innovation Awards during the opening plenary session of the 2022 PDA Universe of Pre-Filled Syringes and Injection Devices in Palm Springs, CA. Awardees were recognized for their technical innovations in advancing the field of bio/pharmaceutical manufacturing.

The Innovation Award is presented to Ascendis A/S and Phillips-Medisize A/S for the SKYTROFA® Auto-Injector. The device is designed to support delivery of the SKYTROFA drug product, which is a lyophilized human growth hormone powder provided in a prefilled dual chamber cartridge. The cartridge is simply clicked into the device and an electromechanical motor controls reconstitution, air-shot, and injection of the mixed drug. The electronics and the user interface assist the user, by ensuring that the needle points upwards during reconstitution and air-shot, by keeping timing of passive mixing and by guiding a manual mixing procedure. Finally, the device injects automatically when it is pressed against the injection site and delivers a clear confirmation of dose delivered.

The Partnership Innovation Award is presented to the Stevanato Group and Bexson Biomedical for the innovation Pain Management Therapy through On-Body Injector System. Optimizing the target product profile opportunity with minimal time to market combination product therapies requires an innovative approach to development and commercialization. Bexson Biomedical and the Stevanato Group collaborated to optimize subcutaneous delivery of a novel pain management therapy based on a controlled substance. This therapy provides an alternative to highly addictive and easily misused opioids. Through this real-time collaboration, the companies are co-developing a novel combination product with a device constituent that is specifically designed to inhibit abuse and misuse of the pre-filled and preloaded integrated drug while providing ease of use to the patient.

“I want to congratulate the companies that received the 2022 PDA Drug Delivery Innovation Awards,” said Richard Johnson, PDA President & CEO. “We are pleased to recognize the winners and all the companies considered at the first in-person Universe of Pre-Filled Syringes and Injection Devices Conference since 2019.”

For more information on the 2022 PDA Universe of Pre-Filled Syringes and Injection Devices Conference, click here.

Share article on social media or email:

Multiple COVID-19 Vaccine Doses Reduce Symptoms, Length of Illness, and Need for Medical Care


“Everyone wants to get back to normal even though hundreds of people still die from COVID-19 in the U.S. every day,” says Abt Health Economics Principal Associate Lauren Olsho, a co-author of the article. “COVID-19 is still very much with us.”

A study of essential and frontline workers with COVID-19 showed that two or three mRNA vaccine doses produced significant benefits. The study in the Journal of the American Medical Association found that recent vaccinations reduced fever and chills, hours of work missed, the need for medical care, and the amount of virus in the bloodstream (viral load) compared with those who were unvaccinated.

The study for the Centers for Disease Control and Prevention (CDC), conducted by a team that included Abt Associates researchers, involved 1,199 participants from six U.S. states who collected nasal specimens weekly–regardless of symptoms and at the onset of symptoms—from December 14, 2020, to April 19, 2022, and tested positive for COVID-19 infection. The study found that two or three vaccine doses less than 150 days before a Delta infection and three doses before an Omicron infection were significantly associated with milder COVID-19 symptoms, while two doses before either variant were significantly associated with a lower viral load.

The study confirmed substantial differences between Delta and Omicron. While only 3.9 percent of Delta infections were asymptomatic, 20.2 percent of Omicron infections were. If people didn’t know they had Omicron, they could have been unwitting spreaders and contributed to Omicron’s higher transmission rate.

The report noted that the precision and statistical significance of some estimates varied and could have been affected by “confounders,” that is, non-medical factors. For example, different employer isolation protocols could affect the number of work hours missed.

“These factors are a growing issue for this kind of research as people’s behavior changes, especially when vaccinated and unvaccinated people also behave differently in other ways,” says Abt Health Economics Principal Associate Lauren Olsho, a co-author of the article. “Our study suggests staying up to date with your vaccinations and boosters can help keep you from getting as sick. But especially if we do see a big winter surge, additional precautions like masking can still be another layer of protection even if you are vacinated. ”

“It’s hard to say what will happen from here as masking becomes less common across the board. Everyone wants to get back to normal even though hundreds of people still die from COVID-19 in the U.S. every day,” she added. “COVID-19 is still very much with us.”

                                                                 ###

About Abt Associates

Abt Associates is a global consulting and research firm that combines data and bold thinking to improve the quality of people’s lives. We partner with clients and communities to advance equity and innovation—from creating scalable digital solutions and combatting infectious disease, to mitigating climate change and evaluating programs for measurable social impact—and more.

http://www.abtassociates.com

Contact: Stan Crock

stan_crock@abtassoc.com

(301) 347-5402

Share article on social media or email:

Flourish Research Expands with Keystone Clinical Acquisition


We are excited to add Keystone to our expanding company, especially given Dr. Verghese’s position as a thought leader in CNS research and the deep relationships Keystone has developed with sponsor customers – Reinhold Schulz, CEO, Flourish Research.

Flourish Research announces the acquisition of Keystone Clinical Studies, adding to the rapidly expanding Flourish enterprise. Keystone, which is in the greater Philadelphia area, is a leader in Alzheimer’s Disease and other CNS research and the addition of the site expands Flourish’s reach in these core areas of research.

Keystone was founded in 2003 by Dr. Cherian Verghese, who will continue to lead the organization. Dr. Verghese, a psychiatrist by training and a founding member of the CNS Summit, has spent more than 30 years focused on conducting clinical research and will assist with Flourish’s future strategy in this therapeutic area. Dr. Verghese and the current management team will continue in their roles at Keystone.

Reinhold Schulz, CEO of Flourish Research, said, “We are excited to add Keystone to our expanding company, especially given Dr. Verghese’s position as a thought leader in CNS research and the deep relationships Keystone has developed with sponsor customers. It has been greatly satisfying to watch the successful integration of our sites over the past few months, and I’m thrilled to continue growing Flourish into a national market leader within the clinical research site space.

Dr. Verghese, of Keystone Clinical, said, “We believe we can add significant value to Flourish by enhancing their CNS capabilities and collaborating with the existing sites. I am looking forward to working with Flourish’s executive team to accelerate growth at Keystone and across Flourish Research.”

About Flourish Research:

Flourish Research is a leading clinical trial organization, created to strategically acquire, integrate, and operate the best clinical trial sites in North America. Flourish started as some of the most recognized trial sites in the industry including Clinical Trials of Texas, Excel Medical Clinical Trials, Clinical Site Partners, Great Lakes Clinical Trials, and Keystone Clinical Studies.

Flourish sites conduct Phase I-IV studies across therapeutic areas where they have deep expertise, including Cardiology/Metabolic Disease/Renal, CNS, Pulmonology, and Vaccines.

Share article on social media or email:

Precision Edge Surgical Products Receives Marmon ‘Automation of the Year’ Award


News Image

“This award is yet another example to our customers and the market of our commitment to remain the industry leader through continued investment in our products, technology, and people,” says Precision Edge President Todd Fewins.

Precision Edge Surgical Products Company, a global leader in contract manufacturing of orthopedic and medical device instruments, is the recent recipient of the “Automation of the Year” award from parent company Marmon Holdings, Inc., a Berkshire Hathaway company.

“This is a direct result of our focused automation and technology strategy that we have been implementing for many years,” says Precision Edge President Todd Fewins. “I am incredibly pleased and could not be prouder of our automation, engineering, and operations teams that continue to successfully execute our mission. This award is yet another example to our customers and the market of our commitment to remain the industry leader by continuing to invest in our products, technology, and people.”

Precision Edge is part of Marmon Holdings, which comprises 11 groups and more than 100 autonomous businesses. Marmon’s Innovation Award recognizes companies and projects that leverage innovation to drive their businesses forward. Precision Edge received this award by implementing five automation projects in 2021 with a significant investment in state-of-the-art equipment. The company previously implemented several other automation projects, and have more scheduled over the next several years with specialized and often custom equipment and technology, designed for high-precision tolerance medical manufacturing.

“It is exciting to be a part of a company that has such a strong commitment to technology advancement that will provide sustainable growth to our business,” says Jordan Verdelli, automation engineer. “It truly gives us a sense of pride and security that we can remain a competitive leader in our markets. Having our employees buy into our culture and automation push has been extremely rewarding. This would not be possible without the entire team’s effort.”

Precision Edge says the timing of executing their automation strategy could not have come at a better time. It not only helps them remain competitive through process improvements, but assists in supplementing the labor challenges facing all industries.

Precision Edge is a member of Colson Medical, LLC, which is majority owned by Marmon Holdings, Inc., a Berkshire Hathaway company. Marmon’s 20,000-plus team members serve diverse industries and markets worldwide.

Share article on social media or email: